Tuesday, February 17, 2026

Cognetivity Looks To Raise $3.0 Million To Fund US Expansion

Cognetivity Neurosciences (CSE: CGN) is looking to close out the year with a capital raise. The firm last night indicated it intends to conduct a non-brokered private placement for gross proceeds of $3.0 million.

The financing will see the company sell roughly 5.5 million units, with each unit being priced at $0.55 per each. Each unit is set to contain one common share and one half of a purchase warrant, with each warrant valid for a period of three years and containing an exercise price of $0.85 per share.

Proceeds from the offering are to be used to expand the firms operations in the US, customer and technical support, marketing, and general operations.

The financing is currently slated to close by January 31, 2022.

Cognetivity Neuroscience last traded at $0.56 on the CSE.


FULL DISCLOSURE: Cognetivity Neurosciences Ltd is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Cognetivity Neurosciences Ltd on The Deep Dive, with The Deep Dive having full editorial control. We may buy or sell securities in the company at any time. Not a recommendation to buy or sell. We may buy or sell securities in the company at any time. Always do additional research and consult a professional before purchasing a security.

Video Articles

Eldorado Gold: The $3.8 Billion Foran Mining Acquisition

Silver Tiger’s $2.35B Silver Blueprint: Two Mines, One Perfect Metals Market

Gold Is At Records. Barrick Mining Is Printing Cash. The Stock Still Fell. | Q4 Earnings

Recommended

Canadian Copper Plans 2,500 Metre Drill Program For 2026

Mercado Receives Permits For Planned 3,000 Metre Drill Program At Copalito

Related News

Cognetivity Expands To Asian Market Via Pilot Program In Singapore

Cognetivity Neurosciences (CSE: CGN) continues to expand upon its global reach, this morning announcing its...

Tuesday, July 5, 2022, 08:01:43 AM

Cognetivity To Assist In Effective Delivery Of Recently Approved Alzheimer’s Drugs

Cognetivity Neurosciences (CSE: CGN) is set to benefit from a recent ruling by the Centers...

Tuesday, June 6, 2023, 10:02:40 AM

Cognetivity To Deploy Cognitive Assessment Tool Across Largest Healthcare Network In UAE

Cognetivity Neurosciences (CSE: CGN) continued to take the Middle East by storm this morning. The...

Thursday, June 2, 2022, 07:53:30 AM

Cognetivity Neurosciences Signs Commercial Deal With Dubai Health Authority

Cognetivity Neurosciences (CSE: CGN) continues to expand the deployment of its Integrated Cognitive Assessment, or...

Wednesday, March 2, 2022, 09:30:37 AM

Cognetivity To Study Use Of Cognitive Tool To Detect Concussions From Sports

Cognetivity Neuroscience (CSE: CGN) is looking to expand the scope of its cognitive testing platform....

Thursday, May 5, 2022, 07:57:56 AM